Neurologian yksikkö
Department of Neurology

Julkaisut 1990-1990
Publications 1990-1990

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Halonen T, Pitkänen A, Riekkinen PJ. Administration of vigabatrin (gamma-vinyl-GABA-aminobutyric acid) affects the levels of both inhibitory and excitatory amino acids in rat cerebrospinal fluid. J Neurochem 1990:55:1870-1874.
2 Riekkinen P, Sivenius J. Aivoverenkierron iskeemisten häiriöiden lääkehoito. Duodecim 1990:106:1409-1410.
3 Sirviö J, Valjakka A, Riekkinen P Jr, Riekkinen PJ. Alzheimerin taudin kokeellisesta tutkimuksesta. Sandoz Report 1990:21:4-7.
4 Mervaala E, Nousiainen U, Tuunainen A, Riekkinen P. Ambulatorinen EEG kohtauksellisten oireiden diagnostiikassa. Suomen Lääkärilehti 1990:45:1602-1606.
5 Riekkinen P Jr. Animal models of age-related degeneration of subcortical regulatory systems. With special reference to cholinergic, noradrenergic and serotonergic systems. University of Kuopio. Series of Reports. Department of Neurology 17. 67 s., liitt
6 Kälviäinen R, Keränen T, Mustonen J, Länsimies E, Riekkinen P. Autonomic nervous system function in Baltic myoclonus epilepsy. Epilepsy Res 1990:5:251-254.
7 Valjakka A, Sirviö J, Pitkänen A, Riekkinen P. Brain amines and neocortical EEG in young and aged rats. Comp Biochem Physiol 1990:96C:299-304
8 Antal M, Freund TF, Polgar E. Calsium binding proteins parvalbumin and calbindin Dzak immunoreactive neurons in the rat spinal cord and dorsal root ganglia. A light and electron microscopic study. J Comp Neurol 1990:295:467-484.
9 Lepola U, Jolkkonen J, Pitkänen A, Riekkinen P, Rimon R. Cerebrospinal fluid monoamine metabolites and neuropeptides in patients with panic disorder. Ann Med 1990:22:237-239.
10 Koponen H, Reinikainen K, Riekkinen PJ. Cerebrospinal fluid somatostatin in delirium II. Changes at the acute stage and at one year follow-up. Psychol Med 1990:20:501-505.
11 Mervaala E, Nousiainen U, Ylinen A (Marseille Consensus Group). Classification of progressive myoclonus epilepsies and related disorders. Ann Neurol 1990:28:113-116.
12 Lepola U, Heikkinen H, Rimon R, Riekkinen P. Clinical evaluation of alprazolam in patients with panic disorder: a double-blind comparison with imipramine. Hum Psychopharmacol Clin Exp 1990:5:159-163.
13 Mervaala E, Andermann F, Quesney LF, Krelina M. Common dopaminergic mechanism for epileptic photosensitivity in progressive myoclonus epilepsies. Neurology 1990:40:53-56.
14 Kiss J, Baimbridge KG, Patel AJ, Freund TF. Comparative topographical localisation of neurons containing parvalbumin and choline acetyltransferase in the medial septum-diagonal band region of the rat. Neuroscience 1990:36:61-72.
15 Riekkinen P Jr, Miettinen R, Sirviö J, Aaltonen M, Riekkinen P. The correlation of passive avoidance deficit in aged rat with the loss of nucleus basalis choline acetyltransferase-positive neurons. Brain Res Bull 1990:25:415-417.
16 Jolkkonen J, Soikkeli R, Hartikainen P, Bissette G, Riekkinen P. CSF neuropeptides in Alzheimer's disease and Parkinson's disease. Anuario Psiquiatrico 1990:1:251-257
17 Reinikainen KJ, Koponen H, Jolkkonen J, Riekkinen PJ. Decreased somatostatin-like immunoreactivity in the cerebrospinal fluid of chronic schizophrenic patients with cognitive impairment. Psychiatry Res 1990:33:307-312
18 Wolters EC, Riekkinen P, Lowenthal A, van der Plaats JJ, Zwart JMT, Sennef C. DGAVP (ORG 5667) in early Alzheimer's disease patients: An international double-blind placebo-controlled multi-center trial. Neurology 1990:40:1099-1102.
19 Lepola U, Nousiainen U, Puranen M, Riekkinen P, Rimon R. EEG and CT findings in patients with panic disorder. Biol Psychiatry 1990:28:721-727.
20 Soininen H, Riekkinen P, Partanen VJ, Pääkkönen A, Helkala EL, Laulumaa V. EEG in the diagnosis of early Alzheimer disease. Kirjassa: Becker RB, Giacobini E, eds. Alzheimer Disease, Current Research in Early Diagnosis, s. 159-169. New York: Taylor & Francis, 1990
21 Soininen H, Unni L, Shillcutt S. Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain. Neurochem Res 1990:12:1185-1190.
22 Riekkinen P Jr, Sirviö J, Jäkälä P, Lammintausta R, Riekkinen P. Effect of alpha2 antagonists and an agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalis. Neuropharmacology 1990:29:993-999.
23 Lahtinen H, Pitkänen A, Tuomisto L, Riekkinen P. Effect of antiepileptic drugs on somatostatin release in vitro. Neuropeptides 1990:17:29-34.
24 Riekkinen P Jr, Sirviö J, Aaltonen M, Riekkinen P. Effects of concurrent manipulation of nicotinic and muscarinic receptors on spatial and passive avoidance learning. Pharmacol Biochem Behav 1990:37:405-410.
25 Riekkinen P Jr, Sirviö J, Valjakka A, Pitkänen A, Partanen J, Riekkinen P. The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning. Behav Neural Biol 1990:54:204-210.
26 Valjakka A, Riekkinen P Jr, Sirviö J, Nieminen S, Airaksinen M, Miettinen R, Riekkinen P. The effects of dorsal noradrenergic bundle lesions on spatial learning, locomotor activity, and reaction to novelty. Behav Neural Biol 1990:54:323-329.
27 Hannila T, Sirviö J, Riekkinen PJ. The effects of gamma-vinyl-GABA on the performance of nucleus basalis-lesioned rats in spatial navigation task. Brain Res 1990:537:363-366.
28 Riekkinen P Jr, Miettinen R, Rummukainen J, Pitkänen A, Paljärvi L, Riekkinen P. The effects of lesioning the basal forebrain cholinergic neurones on CSF AChE activity. Neurosci Res 1990:6:37-43.
29 Riekkinen P Jr, Sirviö J, Hannila T, Miettinen R, Riekkinen P. Effects of quisqualic acid nucleus basalis lesioning on cortical EEG, passive avoidance and water maze performance. Brain Res Bull 1990:24:839-842.
30 Riekkinen P Jr, Sirviö J, Riekkinen P. The effects of THA on medial septal lesion-induced memory defects. Pharmacol Biochem Behav 1990:36:237-241.
31 Tuunainen A, Nousiainen U, Mervaala E, Riekkinen P. Efficacy of a 1- to 3-day ambulatory electroencephalogram in recording epileptic seizures. Arch Neurol 1990:47:799-800.
32 Keränen T, Riekkinen P, Sillanpää M. Epilepsian esiintyvyys aikuisväestössä Itä-Suomessa. Suomen Lääkärilehti 1990:45:515-519.
33 Riekkinen P, Sivenius J, Kilpeläinen H (ESPS Study Group, Kuopio, Finland). European stroke prevention study. Stroke 1990:21:1122-1130.
34 Freund TF, Buzaki G, Leon A, Somogyi P. Hippocampal cell death following ischemia, effects of brain temperature and anaesthesia. Exp Neurol 1990:108:251-260.
35 Kiss J, Patel AJ, Freund TF. Hippocampal projektions of septal neurons containing parvalbumin or choline acetyltransferase. J Comp Neurol 1990:298:362-372.
36 Gulyas AI, Gorcs T, Freund TF. Innervation of different peptide-containing neurons in the hippocampus by GABAergic septal afferents. Neuroscience 1990:37:31-44.
37 Riekkinen P Jr, Sirviö J, Riekkinen P. Interaction between raphe and nucleus basalis magnocellularis in spatial learning. Brain Res 1990:527:342-345.
38 Riekkinen P Jr, Sirviö J, Miettinen R, Riekkinen P. Interaction between raphe dorsalis and nucleus basalis magnocellularis in the regulation of high-voltage spindle activity in rat neocortex. Brain Res 1990:526:31-37.
39 Riekkinen P Jr, Sirviö J, Jäkälä P, Lammintausta R, Riekkinen P. Interaction between the alpha2-noradrenergic and muscarinic systems in the regulation of neocortical high voltage spindles. Brain Res Bull 1990:25:147-149.
40 Koponen H, Riekkinen P. A longitudinal study of cerebrospinal fluid beta-endorphin-like immunoreactivity in delirium: changes at the acute stage and at one-year follow-up. Acta Psychiatr Scand 1990:82:323-326.
41 Helkala E-L. Memory in patients with Alzheimer's disease and demented patients with Parkinson's disease. University of Kuopio. Series of Reports. Department of Neurology 15. 55 s
42 Riekkinen P, Sirviö J, Riekkinen P Jr. Muistin neurobiologiaa. Duodecim 1990:106:1616-1625.
43 Halonen T. Neurotransmitter amino acids in epileptic convulsions and during vigabatrin treatment. University of Kuopio. Series of Reports. Department of Neurology 18. 80 s., liitt
44 Reinikainen K, Soininen H, Riekkinen PJ. Neurotransmitter changes in Alzheimer's disease: Implications to diagnostics and therapy. J Neurosci Res 1990:27:576-586
45 Reinikainen KJ, Riekkinen PJ. Noncholinergic neurotransmitter markers in the CSF of patients with dementia of Alzheimer type. Kirjassa: Fowler CJ, Carlson LA, Gottfries C-G, Winblad B, eds. Biological Markers in Dementia of Alzheimer Type, s. 161-178. London: Smith-Gordon, 1990
46 Lepola U. Panic disorder. A *clinical, neurochemical, neurophysiological and neuroradiological study. University of Kuopio. Series of Reports. Department of Neurology 19. 65 s., liitt
47 Riekkinen PJ, Riekkinen PJ Jr, Soininen H, Reinikainen KJ, Laulumaa V, Partanen VSJ, Halonen T, Paljärvi L. Regulation of EEG delta activity by the cholinergic nucleus basalis. Kirjassa: Maurer K, Riederer P, Beckmann H, eds. Key Topics in Brain Research. Alzheimer's disease, Epidemiology, Neuropathology, Neurochemistry and Clinics, s. 437-445. Wien: Springer, 1990
48 Riekkinen P Jr, Sirviö J, Riekkinen P. Relationship between the cortical choline acetyltransferase content and EEG delta-power. Neurosci Res 1990:8:12-20.
49 Riekkinen P Sr, Helkala E-L, Jolkkonen J, Riekkinen P Jr, Soininen H. The role of beta-endorphin and related peptides in the pathogenesis and treatment of Alzheimer's disease. Drug Dev Res 1990:20:445-451.
50 Freund TF, Gulyas AI, Acsady L, Gorcs T, Toth K. Serotonergic control of the hippocampus via local inhibitory interneurons. Proc Natl Acad Sci U S A 1990:87:8501-8505.
51 Riekkinen P Jr, Sirviö J, Riekkinen P. Similar memory impairments found in medial septal vertical diagonal band of broca and nucleus basalis lesioned rats. Are memory defects induced by nucleus basalis lesions related to the degree of non-specific subcortical cell loss? Behav Brain Res 1990:37:81-88.
52 Antal M, Freund TF, Somogyi P, McIlhinney RAJ. Simultaneous anterograde labelling of two afferent pathways to the same target area with Phaseolus vulgaris leucoagglutinin and Phaseolus vulgaris leucoagglutinin conjugated to biotin or dinitrophenol. J Neurochem Neuroanat 1990:3:1-9
53 Riekkinen P, Pitkänen A. Somatostatin and epilepsy. Metabolism 1990:39:Suppl 2.
54 Koponen H, Reinikainen K, Jolkkonen J, Riekkinen PJ. Somatostatin-like immunoreactivity in the CSF of patients with dementia associated with alcoholism. Acta Neurol Scand 1990:82:289-291.
55 Sivenius MRJ, Savolainen S, Kaski M, Riekkinen PJ. Therapeutic intervention in mentally retarded adult epileptics. Acta Neurol Scand 1990:81:165-167.
56 Fogelholm R. TIA-potilaan hoitolinjat. Suomen Lääkärilehti 1990:45:1237-1239.
57 Kaste M, Fogelholm R. Trombosyytteihin vaikuttavien lääkeaineiden käyttö aivoverenkierron iskeemisissä häiriöissä. Duodecim 1990:106:855-857.
58 Keränen T, Pitkänen A, Riekkinen P. Uutta epilepsian hoitoon. Suomen Lääkärilehti 1990:45:1029-1034.
59 Fogelholm R, Kaste M. Verenpaineen alentaminen aivoverenkiertopotilaalla - tarkennus Sydäntautiliiton verenpainetyöryhmän suositukseen. Suomen Lääkärilehti 1990:45:1722-1723.
60 Fogelholm R, Paetau A. Yleiskunnon romahtaminen, hengityspysähdykset ja vaihtelevat neurologiset oireet 50-vuotiaalla naisella. Duodecim 1990:106:1066-1074.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 24.1.2013 Publications Data Base 24.1.2013